Safety of long-term PPI therapy
- 30 June 2013
- journal article
- research article
- Published by Elsevier BV in Best Practice & Research Clinical Gastroenterology
- Vol. 27 (3), 443-454
- https://doi.org/10.1016/j.bpg.2013.06.001
Abstract
No abstract availableKeywords
This publication has 79 references indexed in Scilit:
- Proton pump inhibitor therapy predisposes to community‐acquired Streptococcus pneumoniae pneumoniaAlimentary Pharmacology & Therapeutics, 2012
- Proton Pump Inhibitors and Histamine-2 Receptor Antagonists Are Associated With Hip Fractures Among At-Risk PatientsGastroenterology, 2010
- Proton pump inhibitors and risk of gastric cancer: a population-based cohort studyBritish Journal of Cancer, 2009
- Influence of Gastric Acid on Susceptibility to Infection with Ingested Bacterial PathogensInfection and Immunity, 2008
- Novel insight in the association between salmonellosis or campylobacteriosis and chronic illness, and the role of host genetics in susceptibility to these diseasesEpidemiology and Infection, 2007
- Use of Proton Pump Inhibitors and the Risk of Community-Acquired PneumoniaArchives of Internal Medicine, 2007
- Risk factors for Salmonella Enteritidis and Typhimurium (DT104 and non-DT104) infections in The Netherlands: predominant roles for raw eggs in Enteritidis and sandboxes in Typhimurium infectionsEpidemiology and Infection, 2005
- Risk of Community-Acquired Pneumonia and Use of Gastric Acid–Suppressive DrugsJAMA, 2004
- A 5‐decade analysis of 13,715 carcinoid tumorsCancer, 2003
- Helicobacter pyloriInfection and the Development of Gastric CancerThe New England Journal of Medicine, 2001